Display options
Cite
Marciniak A, Brasuń J. Somatostatin analogues labeled with copper radioisotopes: current status. J Radioanal Nucl Chem. 2017;313(2):279-289doi: 10.1007/s10967-017-5323-x.
Marciniak, A., & Brasuń, J. (2017). Somatostatin analogues labeled with copper radioisotopes: current status. Journal of radioanalytical and nuclear chemistry, 313(2), 279-289. https://doi.org/10.1007/s10967-017-5323-x
Marciniak, Aleksandra, and Brasuń, Justyna. "Somatostatin analogues labeled with copper radioisotopes: current status." Journal of radioanalytical and nuclear chemistry vol. 313,2 (2017): 279-289. doi: https://doi.org/10.1007/s10967-017-5323-x
Marciniak A, Brasuń J. Somatostatin analogues labeled with copper radioisotopes: current status. J Radioanal Nucl Chem. 2017;313(2):279-289. doi: 10.1007/s10967-017-5323-x. Epub 2017 Jun 13. PMID: 28804185; PMCID: PMC5533839.
Copy Download .nbib Format: NLM
Share it on

J Radioanal Nucl Chem. 2017;313(2):279-289. doi: 10.1007/s10967-017-5323-x. Epub 2017 Jun 13.

Somatostatin analogues labeled with copper radioisotopes: current status.

Journal of radioanalytical and nuclear chemistry

Aleksandra Marciniak, Justyna Brasuń

Affiliations

  1. Department of Inorganic Chemistry, Wroclaw Medical University, Borowska 211A, 50-556 Wroclaw, Poland.

PMID: 28804185 PMCID: PMC5533839 DOI: 10.1007/s10967-017-5323-x

Abstract

Peptide receptor radionuclide therapy (PRRT) is a promising way to treat patients with inoperable tumors or metastatic neuroendocrine tumors. This therapeutic strategy is using radiolabeled peptides, which are capable of selective biding to receptors overexpressed in the cancer cells. One of the group of receptor-avid peptide used in the PRRT are the analogues of somatostatin (SST) connected to the complexes of radionuclides (e.g.

Keywords: Copper radionuclides; Radiopharmaceuticals; Somatostatin; Somatostatin analogues

References

  1. Cancer Treat Rev. 2008 Feb;34(1):13-26 - PubMed
  2. Neuro Endocrinol Lett. 2003 Feb-Apr;24(1-2):21-7 - PubMed
  3. Nucl Med Biol. 2012 Feb;39(2):187-97 - PubMed
  4. J Nucl Med. 2001 Feb;42(2):213-21 - PubMed
  5. Int J Cancer. 1998 Jan 30;75(3):406-11 - PubMed
  6. Bioconjug Chem. 2012 Jul 18;23(7):1470-7 - PubMed
  7. Curr Pharm Des. 2007;13(1):3-16 - PubMed
  8. Theranostics. 2016 Mar 10;6(5):650-65 - PubMed
  9. Dalton Trans. 2014 Jan 21;43(3):1386-96 - PubMed
  10. Mol Cell Endocrinol. 2008 May 14;286(1-2):58-62 - PubMed
  11. Eur J Nucl Med. 1997 Apr;24(4):368-71 - PubMed
  12. J Nucl Med. 2012 Aug;53(8):1207-15 - PubMed
  13. J Med Chem. 2014 Jul 24;57(14):6019-29 - PubMed
  14. Cancer Res. 1998 Feb 1;58(3):437-41 - PubMed
  15. Clin Cancer Res. 2004 Dec 15;10 (24):8674-82 - PubMed
  16. Trends Endocrinol Metab. 2002 Dec;13(10 ):451-7 - PubMed
  17. J Nucl Med. 2011 Jul;52(7):1110-8 - PubMed
  18. Nucl Med Biol. 1997 Jan;24(1):35-43 - PubMed
  19. J Nucl Med. 2008 Nov;49(11):1819-27 - PubMed
  20. Best Pract Res Clin Gastroenterol. 2005 Aug;19(4):595-616 - PubMed
  21. Appl Radiat Isot. 2011 Jan;69(1):68-74 - PubMed
  22. Best Pract Res Clin Endocrinol Metab. 2007 Mar;21(1):111-29 - PubMed
  23. J Nucl Med. 2017 Mar;58(3):451-457 - PubMed
  24. Mol Cell Endocrinol. 2008 May 14;286(1-2):251-61 - PubMed
  25. Med Res Rev. 2012 May;32(3):637-58 - PubMed
  26. J Inorg Biochem. 2004 Nov;98(11):1874-901 - PubMed
  27. Endocr Rev. 1991 Nov;12(4):450-82 - PubMed
  28. Nucl Med Biol. 1999 Apr;26(3):267-73 - PubMed
  29. Biomed Res Int. 2014;2014:786463 - PubMed
  30. Ann Oncol. 1999;10 Suppl 2:S23-9 - PubMed
  31. Nucl Med Biol. 1996 Nov;23(8):957-80 - PubMed
  32. Cancer. 1994 Feb 1;73(3 Suppl):774-8 - PubMed
  33. Eur J Nucl Med. 2001 Sep;28(9):1421-9 - PubMed
  34. Semin Nucl Med. 2006 Jul;36(3):228-47 - PubMed
  35. J Nucl Med. 2011 Sep;52(9):1412-7 - PubMed
  36. J Med Chem. 1999 Apr 22;42(8):1341-7 - PubMed
  37. J Nucl Med. 1995 Dec;36(12 ):2315-25 - PubMed
  38. Mol Imaging. 2014;13:null - PubMed
  39. Front Neuroendocrinol. 1999 Jul;20(3):157-98 - PubMed
  40. Eur J Nucl Med. 2000 Mar;27(3):273-82 - PubMed
  41. Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16436-41 - PubMed
  42. Biometals. 2012 Dec;25(6):1089-112 - PubMed
  43. Bioconjug Chem. 2000 Jul-Aug;11(4):527-32 - PubMed
  44. Life Sci. 1991;49(22):1583-91 - PubMed
  45. Int J Pept. 2013;2013:926295 - PubMed
  46. J Exp Clin Cancer Res. 2010 Mar 02;29:19 - PubMed
  47. Eur J Nucl Med Mol Imaging. 2005 Dec;32(12):1473-80 - PubMed
  48. Clin Cancer Res. 1999 Nov;5(11):3608-16 - PubMed
  49. J Biol Inorg Chem. 2003 Jan;8(1-2):217-25 - PubMed
  50. Pharmacol Ther. 2004 Apr;102(1):61-85 - PubMed
  51. Adv Drug Deliv Rev. 2008 Sep;60(12):1347-70 - PubMed
  52. World J Gastroenterol. 2010 Jun 28;16(24):2963-70 - PubMed
  53. Appl Radiat Isot. 2006 Dec;64(12):1563-73 - PubMed
  54. Science. 1973 Jan 5;179(4068):77-9 - PubMed
  55. Med Res Rev. 2004 May;24(3):357-97 - PubMed
  56. J Nucl Med. 1998 Nov;39(11):1944-51 - PubMed
  57. J Nucl Med. 2015 Jun;56(6):847-54 - PubMed
  58. J Clin Oncol. 2005 Apr 20;23(12):2754-62 - PubMed

Publication Types